In more recent years, research has expanded our understanding of the role of TDP-43 in the progression of different cancers, including breast cancer, cervical cancer, lung cancer, hepatocellular carcinoma, glioblastoma, and melanoma. Here, TARDBP is linked to hepatocellular carcinoma.